DE3403125A1 - Antibiotikum luzopeptin e(pfeil abwaerts)2(pfeil abwaerts), verfahren zu dessen herstellung und diese verbindung enthaltendes, pharmazeutisches mittel - Google Patents

Antibiotikum luzopeptin e(pfeil abwaerts)2(pfeil abwaerts), verfahren zu dessen herstellung und diese verbindung enthaltendes, pharmazeutisches mittel

Info

Publication number
DE3403125A1
DE3403125A1 DE19843403125 DE3403125A DE3403125A1 DE 3403125 A1 DE3403125 A1 DE 3403125A1 DE 19843403125 DE19843403125 DE 19843403125 DE 3403125 A DE3403125 A DE 3403125A DE 3403125 A1 DE3403125 A1 DE 3403125A1
Authority
DE
Germany
Prior art keywords
lucopeptin
luzopeptin
methionine
antibiotic
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19843403125
Other languages
German (de)
English (en)
Inventor
Charles A. Manilus N.Y. Claridge
Terrence W. Fayetteville N.Y. Doyle
Marianne F. Syracuse N.Y. Kammer
Henry Syracuse N.Y. Schmitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of DE3403125A1 publication Critical patent/DE3403125A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19843403125 1983-01-31 1984-01-30 Antibiotikum luzopeptin e(pfeil abwaerts)2(pfeil abwaerts), verfahren zu dessen herstellung und diese verbindung enthaltendes, pharmazeutisches mittel Withdrawn DE3403125A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46257783A 1983-01-31 1983-01-31

Publications (1)

Publication Number Publication Date
DE3403125A1 true DE3403125A1 (de) 1984-10-31

Family

ID=23836950

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19843403125 Withdrawn DE3403125A1 (de) 1983-01-31 1984-01-30 Antibiotikum luzopeptin e(pfeil abwaerts)2(pfeil abwaerts), verfahren zu dessen herstellung und diese verbindung enthaltendes, pharmazeutisches mittel

Country Status (15)

Country Link
JP (1) JPH0645638B2 (fr)
KR (1) KR880001638B1 (fr)
AU (1) AU566569B2 (fr)
BE (1) BE898807A (fr)
CA (1) CA1220746A (fr)
CH (1) CH663415A5 (fr)
DE (1) DE3403125A1 (fr)
FR (1) FR2540116B1 (fr)
GB (1) GB2134119B (fr)
GR (1) GR81749B (fr)
IT (1) IT1175927B (fr)
MY (1) MY8800015A (fr)
NL (1) NL8400237A (fr)
SE (1) SE464582B (fr)
ZA (1) ZA84613B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643871A (en) * 1993-11-23 1997-07-01 Bristol-Meyers Squibb Company Antitumor antibiotics
GB2294265A (en) * 1994-10-20 1996-04-24 Merck & Co Inc Cyclic depsipeptides obtained from Actinomycete sp.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3012565A1 (de) * 1979-04-02 1980-10-23 Bristol Myers Co Antitumor-antibakterielle mittel

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3012565A1 (de) * 1979-04-02 1980-10-23 Bristol Myers Co Antitumor-antibakterielle mittel

Also Published As

Publication number Publication date
ZA84613B (en) 1984-09-26
MY8800015A (en) 1988-12-31
CA1220746A (fr) 1987-04-21
GB8402410D0 (en) 1984-02-29
CH663415A5 (de) 1987-12-15
SE464582B (sv) 1991-05-13
NL8400237A (nl) 1984-08-16
IT8419348A0 (it) 1984-01-27
FR2540116A1 (fr) 1984-08-03
JPS59173091A (ja) 1984-09-29
AU2372184A (en) 1984-08-02
FR2540116B1 (fr) 1989-08-18
GR81749B (fr) 1984-12-12
IT1175927B (it) 1987-08-12
KR880001638B1 (ko) 1988-09-03
JPH0645638B2 (ja) 1994-06-15
SE8400450D0 (sv) 1984-01-30
GB2134119B (en) 1986-04-30
AU566569B2 (en) 1987-10-22
GB2134119A (en) 1984-08-08
KR840007106A (ko) 1984-12-05
BE898807A (fr) 1984-07-31
SE8400450L (sv) 1984-08-01

Similar Documents

Publication Publication Date Title
DE3320342C2 (fr)
DE2743654C3 (fr)
DE2813021C2 (de) Antibiotika KA-6606 I, II, III und IV, diese Antibiotika enthaltende Mittel und Verfahren zur Herstellung dieser Verbindungen
DE2718782C2 (fr)
CH630957A5 (de) Verfahren zur herstellung von neuen antibiotischen verbindungen auf basis eines bohemsaeurekomplexes.
DE2537902C2 (de) Als Rifamycin P, Q, R und U bezeichnete Antibiotika und Verfahren zu deren Herstellung
DE2715255C3 (de) Anthracyclinglykoside MA 144-M, und MA 144-M2 und deren Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
DE3234203C2 (fr)
DE2839668C2 (fr)
DE2724441A1 (de) Anthracyclinglycoside, verfahren zu ihrer herstellung und arzneimittel
DE3012014C2 (de) Istamycine, Verfahren zu deren Herstellung sowie Verwendung derselben als antibakterielle Mittel
DE69816621T2 (de) Macrolide mit antitumoraktivität
CH631740A5 (en) Process for the preparation of maytansinol and its derivatives
DE2833689C2 (fr)
DE3403125A1 (de) Antibiotikum luzopeptin e(pfeil abwaerts)2(pfeil abwaerts), verfahren zu dessen herstellung und diese verbindung enthaltendes, pharmazeutisches mittel
DE2652677C2 (de) Antibiotica 890A↓1↓ und 890A↓3↓, Verfahren zu ihrer Herstellung und diese Antibiotika enthaltende antibakterielle Mittel
DE3003359C2 (fr)
DE2746209C2 (fr)
DE2725163C2 (fr)
DE2849666A1 (de) Verfahren zur herstellung des antibiotikums c-15003 p 4
EP0186807B1 (fr) Dérivés d'anthracyclines, leur préparation microbiologique et leur utilisation comme médicament
DE3407979C2 (fr)
US4003902A (en) Naphthyridinomycin antibiotics
CH637137A5 (en) Antibiotic and process for its preparation
DE2039990C2 (de) Neue Antibiotika B-5050 A bis F (Maridomycin I bis VI), Verfahren zu ihrer Herstellung und ihre pharmazeutische Zubereitung

Legal Events

Date Code Title Description
8127 New person/name/address of the applicant

Owner name: BRISTOL-MYERS SQUIBB CO. (N.D.GES.D.STAATES DELAWA

8128 New person/name/address of the agent

Representative=s name: KINZEBACH, W., DIPL.-CHEM. DR.PHIL. RIEDL, P., DIP

8110 Request for examination paragraph 44
8125 Change of the main classification

Ipc: C07K 7/06

8136 Disposal/non-payment of the fee for publication/grant